About: Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 April 2012

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2012 (ast) наукова стаття, опублікована у квітні 2012 (uk) scientific article published on 13 April 2012 (en) مقالة علمية نشرت في 13 أبريل 2012 (ar)
publication date	wds:Q37531368-2129DAE1-6D6F-4D38-8BF4-A250E0EB1859
publication date	2012-04-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37531368-90FF7E5B-E87A-4864-9EB5-DDB49211E347
language of work or name	English
exact match	wds:Q37531368-22C86BBC-1E0B-4E05-9ACB-5837DF1281F1
exact match	https://scigraph.springernature.com/pub.10.1007/s10549-012-2055-z
cites work	wds:Q37531368-05B6E3BB-4EDB-4058-BD71-467877623E37 wds:Q37531368-0882EEA3-A054-4A41-AC55-21BD9B962E14 wds:Q37531368-08DF4C28-CB96-419E-A0FE-19379C70E397 wds:Q37531368-0B288A69-FE0D-499E-A646-0DC23DF2DFCA wds:Q37531368-19D0C553-C074-4734-93E8-829AC4115182 wds:Q37531368-1DC03471-373F-498D-9CF8-1D1280E5D8DE wds:Q37531368-2203A4EE-4F39-4078-BB4F-C581F4B0744F wds:Q37531368-26C629A2-9708-4AE7-A5CE-AF487D40C918 wds:Q37531368-26CEC040-463D-4354-947D-9A4F83C27F1D wds:Q37531368-34AB406C-0E38-4329-82C4-13E55C343AFD wds:Q37531368-34E07DB5-EA41-4A56-9203-3458BD28DC2C wds:Q37531368-365765F4-572A-42C3-9717-411A4BDE21ED wds:Q37531368-4432C645-C67C-49A8-9DE8-58B66D62A5E4 wds:Q37531368-4E3009A2-7FB3-441C-A056-4AAC2498F3A1 wds:Q37531368-53772720-71D3-4991-A089-E2EE6F99165B wds:Q37531368-66284BD9-D0D8-4D1C-ACB6-887CD44D682D wds:Q37531368-6C104302-837F-4A04-A460-FC35993A6685 wds:Q37531368-700BA63B-13AD-41C5-9085-0C95B48091D5 wds:Q37531368-74FF439A-AFF8-4B28-BD00-14B6910FC175 wds:Q37531368-776BCE4F-CBEF-4F2C-8A96-A479703C79C9 wds:Q37531368-7B2F992B-32CB-453E-83C5-3E05925E9A8C wds:Q37531368-8115A21F-4DF2-42AA-AE54-68CC8ABF5485 wds:Q37531368-811CD0FF-4249-4EC1-8CA6-86DB8C7FEF7B wds:Q37531368-84B847E9-77ED-4350-8422-34E155E77056 wds:Q37531368-875D3530-6407-4AF5-9D57-CB1D65707438 wds:Q37531368-8C097673-0020-44A6-BCB5-AEF990580E70 wds:Q37531368-955DEE29-0469-47F4-8D83-5CC823B83943 wds:Q37531368-9EC4BC34-4893-4BB4-BD78-BBE7F1E48D9F wds:Q37531368-AC277074-AECF-440B-BCF4-143FE8135A0D wds:Q37531368-B558BC97-D316-4E72-B786-8036BB54D8F4 wds:Q37531368-B76B176C-A6CF-444A-9904-B33B664B5487 wds:Q37531368-BA3CA933-B9D0-40FE-BE14-DAF7B949BBA8 wds:Q37531368-BB7AA47C-A9F0-45FC-B12A-F260EC0D2F73 wds:Q37531368-BFF1E90E-87FD-4EFC-959C-2B2B5B4A7493 wds:Q37531368-C573F45F-5796-4E41-9B9A-488E36F8C8F8 wds:Q37531368-D18DCBA1-4289-462F-BBA0-0C5410A6A93F wds:Q37531368-D2482019-1228-45E7-89B3-7264FBBC1194 wds:Q37531368-D35252CA-77D7-4C20-B77C-D6E2C368853E wds:Q37531368-D56B1461-6B4B-4F83-9539-9CAFB0CD0F3B wds:Q37531368-D61D6C8C-78D4-4A29-A3D6-D3DC69AC2F37 wds:Q37531368-ECC549BC-4A42-48A3-8E10-C056021C4800 wds:Q37531368-F863CB13-3AB8-4A79-81C8-BBCCEA093AF9 wds:Q37531368-F9107D16-B8A9-4FB6-968C-1DECAE1A7A6A
cites work	Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3 The polycomb group protein EZH2 is involved in progression of prostate cancer Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells Basal-like breast cancer: a critical review Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2 Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 Polycomb group protein ezh2 controls actin polymerization and cell signaling. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast Differences in risk factors for breast cancer molecular subtypes in a population-based study Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status Trends in breast cancer by race and ethnicity: update 2006. Ethnicity and breast cancer: factors influencing differences in incidence and outcome Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Aberrations of EZH2 in cancer Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software